Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares dropped 10.8% during mid-day trading on Friday . The company traded as low as GBX 15.61 ($0.20) and last traded at GBX 15.61 ($0.20). Approximately 75,188 shares changed hands during trading, a decline of 2% from the average daily volume of 77,003 shares. The stock had previously closed at GBX 17.50 ($0.22).
Celadon Pharmaceuticals Price Performance
The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 194.82. The business’s 50-day moving average price is GBX 20.83 and its 200 day moving average price is GBX 39.47. The company has a market capitalization of £10.60 million, a P/E ratio of -192.50 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Read More
- Five stocks we like better than Celadon Pharmaceuticals
- Golden Cross Stocks: Pattern, Examples and Charts
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Top 3 ETFs to Hedge Against Inflation in 2025
- Expert Stock Trading Psychology Tips
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
